Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
E: [email protected]
Dr. Carroll is a Senior Pharmaceutical Quality Assessor within the Division of Biotechnology Manufacturing, Office of Pharmaceutical Manufacturing Assessment, OPQ, CDER, FDA and serves as primary and secondary reviewer of biologic license applications and supplements, including biosimilars. She has participated on multiple pre-license inspections for protein biological products with a focus on aseptic processing and sterility assurance. Prior to joining FDA in 2017, she completed post-doctoral studies at the Institute for Human Virology, University of Maryland, Baltimore and taught college microbiology courses. She holds a PhD in in Microbiology from the University of Virginia.